Clinical Trials Directory

Trials / Sponsors / Sinovac Research and Development Co., Ltd.

Sinovac Research and Development Co., Ltd.

Industry · 22 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine
Pneumococcal Infectious Disease
Phase 12024-01-04
WithdrawnEfficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and
COVID-19
Phase 32023-02-20
SuspendedSafety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Diff
COVID-19
Phase 42022-12-20
SuspendedImmunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVa
COVID-19
Phase 22022-12-15
UnknownEffectiveness of Inactivated COVID-19 Vaccine of the First Booster Dose
COVID-19
—2022-07-30
CompletedImmunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Varian
COVID-19
Phase 32022-06-01
WithdrawnImmunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated Vaccine i
COVID-19
Phase 22022-02-10
CompletedImmunogenicity of an Inactivated COVID-19 Vaccine
COVID-19
Phase 42022-01-08
CompletedSafety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years
COVID-19
Phase 32021-11-27
CompletedImmunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)
COVID-19
Phase 42021-11-05
CompletedEfficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents
COVID-19
Phase 32021-09-10
CompletedEffectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic
COVID-19
—2021-08-17
UnknownLot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine Between Different Workshops in Healthy Children Ag
COVID-19
Phase 42021-07-27
CompletedImmunogenicity and Safety of an Inactivated COVID-19 Vaccine
COVID-19
Phase 42021-07-09
UnknownClinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults
COVID-19
Phase 42021-06-19
CompletedSafety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults
COVID-19
Phase 42021-06-05
CompletedLot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults
COVID-19
Phase 42021-05-11
CompletedStudy on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine
COVID-19, Influenza
Phase 42021-03-23
CompletedSafety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19
COVID-19
Phase 1 / Phase 22020-10-31
CompletedStudy of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of t
Covid19
Phase 32020-10-31
CompletedSafety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)
COVID-19
Phase 1 / Phase 22020-04-16
CompletedSafety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants
Mumps
Phase 32016-01-01